Pharmacovigilance + Pharmacogenetics Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Define pharmacovigilance

A

Indentification, assessment and prevention of adverse drug reactions while optimising benefits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the most common clinical adverse event?

A

Drug reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How many cases of adverse drug reactions would be enough to stop use of drug today?

A

10 cases internationally would be enough

Adequate testing, government regulation, reporting systems, most medications cross the placenta (avoiding use in pregnancy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is thalidomide used for currently?

A
  • Leukaemia
  • Elder patients

Balance between risks + harm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Give some examples of adverse drug reactions that are considered serious

A
  • Fatal, life threatening
  • Prolonged hospitalisation
  • Long term disability
  • Congenital abnormalities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Define ‘adverse drug reactions’ and give the 2 main types

A
  • ADR’s = response attributable to therapeutic when given within normal therapeutic range (happens when drug given within therapeutic range)

Unintended

Noxious (causing harm)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Distinguish between Type A (augmented) and Type B (bizarre) adverse drug reactions

A

Type A (augmented):

  • Dose related
  • Predictable
  • Common
  • Reversible (on stopping/reducing dose)
  • Dose adjustment

Type B (bizarre):

  • Not dose related
  • Unpredictable
  • Uncommon
  • Serious/irreversible
  • Need to stop treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Give some examples of Type A and Type B adverse drug reactions

A

Type A:

  • Bleeding; warfarin
  • Hypoglycaemia; diabetes medication

Type B:

  • Anaphylaxis; penicillin
  • Agranulocytosis; clozapine (schizophrenia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is agranulocytosis?

A

Acute condition involving a severe and dangerous leukopenia (lowered white blood cell count), most commonly of neutrophils, and thus causing a neutropenia in the circulating blood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is a risk of the COCP?

Which generation of oral contraceptives are used currently?

A

VTE

2nd generation oral contraceptives (safer than 3rd generation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Define pharmacogenetics

A

How individual gene may affect response to drug or drug response on body

How phenotypic differences affect therapeutics

Population vs individual

Consideration of pharmacogenetics with pharmacovigilance to reduce preventable adverse drug reactions

Person to person variability explained; eg drug reactions, response to therapeutics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Give some examples of drugs that are affected by pharmacogenetics

A
  • Statins
  • B-blockers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Give 2 examples where knowledge of pharmacogenetics has improved patient care

A
  • Abacavir + hypersensitivity; in some patients treated for HIV
  • Split antigen reaction
  • Screening for split antigen resulted in reduction in reactivity
  • Cutaneous reaction; Stevens-Johnson syndrome/severe toxic epidermal necrolysis); in patients taking carbamazepine (anti-epileptic)
  • Reaction to another split antigen; predominantly in asian populations
  • Screening, identification + avoidance in certain patient groups
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Explain the involvement of pharmacogenetics in primary step 1 antihypertensive treatment

A

Response to medications dictated by RAAS activity

Renin lower in African/Carribean populations so ACEi/ARB not primary choice for reducing BP (use CCB’s instead 1st line)

Lower response to ACEi/ARB compared to white cuacasians

CCB’s work in both populations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Is angioedema more prevalent in African Carribean or young white caucasian populations?

A

African/Carribean

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

GIve some exmaples of how genetic polymorphisms can affect PK and PD

A
  • Chnages in PK
  • Receptor structure
  • Enzyme activity
  • Immune response
17
Q

How can a point mutation of ALDH2 coding for aldehyde dehydrogenase in East Asian and Northern European populations affect their alcohol handling?

A

Aldehyde dehydrogenase deficiency

Single amino acid change

Accumulation of acetaldehyde; red flushing

Reduced acetate production

18
Q

Give 2 other examples where genetic polymorphisms influence prescribing

A
  • Metabolic CYP 450 enzymes
  • Warfarin + INR: metabolised by different CYP’s thus no standard dose warfarin (variability of handling between individuals)
19
Q

The CYP 2D6 isoform is responsible for metabolising what kinds of drugs?

A
  • 25% of drugs metabolised by CYP 2D6
  • Antidepressants
  • Antipsychotics
  • B-blockers
  • Opioid analgesics

Great variability in rate of drug metabolism by CYP 2D6

20
Q

6% of the Caucasian population carry 2 null alleles at the CYP 2D6 gene. How can this affect drug metabolism?

A
  • No ability to metabolise drugs usually metabolised by CYP 2D6 isoform
  • Decreased first pass metabolism; B-blockers (metoprolol) + bradycardia due to reduced metabolism thus accumulation of metoprolol
21
Q

How can PG be applied to therapeutics?

A
  • Personalised drug therapy
  • Screening for gene variants/polymorphism
  • Genetic sequences of target receptors/enzymes
  • To predict ADR’s: statins and muscle damage/rhabdomyolysis, myalgia - monitoring outcomes + adherence
  • Vaccines for allergies; prophylactic vaccine failure + ADRS, following genetic polymorphisms and their effect on innate + adaptive immune response
22
Q

Explain the effects of CYP 2D6 mutations on codeine metabolism

A

Codeine is a pro-drug, which is metabolised into its active form morphine, by CYP 2D6